142
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies

, , &
Pages 4799-4818 | Published online: 20 Sep 2016

References

  • ChenRWangSZhangJChenMWangYAloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer studyDrug Deliv201522566667424512431
  • NayakVGincyTBPrakashMHepatoprotective activity of Aloe vera gel against paracetamol induced hepatotoxicity in albino ratsAsian J Phar Biol Res2011129498
  • LiuYXShenNYLiuCLvYImmunosuppressive effects of emodin: an in vivo and in vitro studyTransplant Proc20094151837183919545739
  • BarnardDLHuffmanJHMorrisJLBWoodSGHughesBGSidwellRWEvaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalo-virusAntiviral Res199217163771310583
  • YenG-CDuhP-DChuangD-YAntioxidant activity of anthraquinones and anthroneFood Chem2000704437441
  • ChenRZhangJHuYWangSChenMWangYPotential antineoplastic effects of aloe-emodin: a comprehensive reviewAm J Chin Med2014420227528824707862
  • DuanH-GWeiY-HLiB-XQinH-YWuX-AImproving the dissolution and oral bioavailability of the poorly water-soluble drug aloe-emodin by solid dispersion with polyethylene glycol 6000Drug Dev Res2009705363369
  • TianKZhangHChenXHuZDetermination of five anthraquinones in medicinal plants by capillary zone electrophoresis with β-cyclodextrin additionJ Chromatogr A20061123113413716806252
  • ChouT-HLiangC-HThe molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeationChem Res Toxicol200922122017202819928967
  • KatheNHenriksenBChauhanHPhysicochemical characterization techniques for solid lipid nanoparticles: principles and limitationsDrug Dev Ind Pharm201440121565157524766553
  • El-RefaieWMElnaggarYSEl-MassikMAAbdallahOYNovel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: development, in-vitro appraisal and in-vivo studiesInt J Pharm20154861889825818063
  • El-RefaieWMElnaggarYSEl-MassikMAAbdallahOYNovel self-assembled, gel-core hyaluosomes for non-invasive management of osteoarthritis: in-vitro optimization, ex-vivo and in-vivo permeationPharm Res20153292901291125777613
  • ElnaggarYSEtmanSMAbdelmonsifDAAbdallahOYNovel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studiesInt J Nanomedicine201510545926346130
  • JainVSwarnakarNKMishraPRPaclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapyBiomaterials201233297206722022809646
  • YangDArmitageBMarderSRCubic liquid-crystalline nanoparticlesAngew Chem Int Ed2004433444024409
  • SpillmannCMNaciriJAlgarWRMedintzILDelehantyJBMultifunctional liquid crystal nanoparticles for intracellular fluorescent imaging and drug deliveryACS Nano2014876986699724979226
  • ChenYMaPGuiSCubic and hexagonal liquid crystals as drug delivery systemsBiomed Res Int2014201412
  • BodeJKuntscheJFunariSBunjesHInteraction of dispersed cubic phases with blood componentsInt J Pharm20134481879523524124
  • ZengNHuQLiuZPreparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailabilityInt J Pharm20124241586622240390
  • AngelovBAngelovaAPapahadjopoulos-SternbergBHoffmannSVNicolasVLesieurSProtein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism studyJ Phys Chem B2012116267676768622720820
  • AngelovaAAngelovBDrechslerMGaramusVMLesieurSProtein entrapment in PEGylated lipid nanoparticlesInt J Pharm2013454262563223791734
  • OtsukaHNagasakiYKataokaKPEGylated nanoparticles for biological and pharmaceutical applicationsAdv Drug Deliv Rev200355340341912628324
  • LiS-DHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317820338200
  • EspositoEEbloviNRasiSLipid-based supramolecular systems for topical application: a preformulatory studyAAPS PharmSci2003546276
  • EspositoECortesiRDrechslerMCubosome dispersions as delivery systems for percutaneous administration of indomethacinPharm Res200522122163217316267633
  • YangZChenMYangMChenJFangWXuPEvaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infectionInt J Nanomedicine2014932724421641
  • WolframJSuriKHuangYEvaluation of anticancer activity of celastrol liposomes in prostate cancer cellsJ Microencapsul201431550150724654943
  • European Pharmacopoeia 6th Edition2007EDQM (European Directorate for the Quality of Medicines & Health Care), Council of EuropeStrasbourg Cedex, France
  • ReitmanSFrankelSA colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminasesAm J Clin Pathol19572815613458125
  • TabaccoAMeiattiniFModaETarliPSimplified enzymic/colorimetric serum urea nitrogen determinationClin Chem1979252336337759035
  • BowersLDWongETKinetic serum creatinine assays. II. A critical evaluation and reviewClin Chem19802655555617020989
  • JinXZhangZ-HLiS-LA nanostructured liquid crystalline formulation of 20 (S)-protopanaxadiol with improved oral absorptionFitoterapia201384647123006538
  • SherifSBendasERBadawySThe clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkleEur J Pharm Biopharm201486225125924056055
  • DeshpandeSVenugopalERamagiriSBellareJRKumaraswamyGSinghNEnhancing cubosome functionality by coating with a single layer of poly-ε-lysineACS Appl Mater Interfaces2014619171261713325184793
  • ElgindyNElkhodairyKMolokhiaAElzoghbyALyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluationDrug Dev Ind Pharm201137444645521446829
  • DrieverCDMuletXWaddingtonLJLayer-by-layer polymer coating on discrete particles of cubic lyotropic liquid crystalline dispersions (cubosomes)Langmuir20132942128911290024033086
  • BoydBJCharacterisation of drug release from cubosomes using the pressure ultrafiltration methodInt J Pharm2003260223924712842343
  • ÖzcanIBouchemalKSegura-SánchezFAbacıÖÖzerÖGüneriTEffects of sterilization techniques on the PEGylated poly (γ-benzyl-L-glutamate) (PBLG) nanoparticlesActa Pharm Sci200951211218
  • MassonVMaurinFFessiHDevissaguetJInfluence of sterilization processes on poly (ε-caprolactone) nanospheresBiomaterials19971843273359068895
  • CavalliRCaputoOCarlottiMETrottaMScarnecchiaCGascoMRSterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticlesInt J Pharm199714814754
  • FrançaÁPelazBMorosMSterilization matters: consequences of different sterilization techniques on gold nanoparticlesSmall201061899519937607
  • PuthliSVaviaPGamma irradiated micro system for long-term parenteral contraception: an alternative to synthetic polymersEur J Pharm Sci200835430731718760352
  • GainzaGPastorMAguirreJJA novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: in vitro bioactivity and in vivo effectiveness in healing-impaired db/db miceJ Control Release2014185516124794895
  • VijayakumarSGanesanSIn vitro cytotoxicity assay on gold nanoparticles with different stabilizing agentsJ Nanomater201220129
  • BarauskasJCervinCJankunecMInteractions of lipid-based liquid crystalline nanoparticles with model and cell membranesInt J Pharm2010391128429120214966
  • FengS-XXuH-PLiJ-SQuL-BRanYLIJ-JDetermination of aloe-emodin in rat plasma by SPE-HPLC and the pharmacokinetic studyChin J New Drugs20128022
  • PaliwalRRaiSVaidyaBEffect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic deliveryNanomedicine20095218419119095502
  • AroraSRajwadeJMPaknikarKMNanotoxicology and in vitro studies: the need of the hourToxicol Appl Pharmacol2012258215116522178382